These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1525350

  • 1. Production of platelet-activating factor in inflammatory exudate.
    Oh-ishi S, Imai Y, Hayashi M.
    J Lipid Mediat; 1992; 5(2):115-20. PubMed ID: 1525350
    [Abstract] [Full Text] [Related]

  • 2. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC, Szpejda M.
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [Abstract] [Full Text] [Related]

  • 3. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB, Li CL, Lam MH, Shen TY.
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [Abstract] [Full Text] [Related]

  • 4. [Effect of glycyrrhizin on the production of platelet-activating factor from rat peritoneal exudate cells].
    Ichikawa Y, Mizoguchi Y, Kioka K, Kobayashi K, Tomekawa K, Morosawa S, Yamamoto S.
    Arerugi; 1989 Apr; 38(4):365-9. PubMed ID: 2783037
    [Abstract] [Full Text] [Related]

  • 5. Presence of immunoreactive platelet-activating factor in peritoneal exudate induced by zymosan in rats.
    Damas J, Prunescu P.
    Arch Int Pharmacodyn Ther; 1993 Apr; 322():115-23. PubMed ID: 8215712
    [Abstract] [Full Text] [Related]

  • 6. Involvement of platelet-activating factor in zymosan-induced rat pleurisy.
    Imai Y, Hayashi M, Oh-ishi S.
    Lipids; 1991 Dec; 26(12):1408-11. PubMed ID: 1819742
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor.
    Heuer HO, Casals-Stenzel J, Muacevic G, Weber KH.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):962-8. PubMed ID: 2262914
    [Abstract] [Full Text] [Related]

  • 8. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
    Sansom JE, Brooks J, Burton JL, Archer CB.
    Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
    [Abstract] [Full Text] [Related]

  • 9. [Evaluation of time course and inter-relationship of inflammatory mediators in experimental inflammatory reaction].
    Ohishi S.
    Yakugaku Zasshi; 2000 May; 120(5):455-62. PubMed ID: 10825809
    [Abstract] [Full Text] [Related]

  • 10. Key role of complement activation and platelet-activating factor in exudate formation in zymosan-induced rat pleurisy.
    Imai Y, Hayashi M, Oh-ishi S.
    Jpn J Pharmacol; 1991 Oct; 57(2):225-32. PubMed ID: 1812301
    [Abstract] [Full Text] [Related]

  • 11. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J.
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [Abstract] [Full Text] [Related]

  • 12. Platelet-activating factor antagonists suppress the generation of tumor necrosis factor-alpha and superoxide induced by lipopolysaccharide or phorbol ester in rat liver macrophages.
    Zhang F, Decker K.
    Eur Cytokine Netw; 1994 Jan; 5(3):311-7. PubMed ID: 7948767
    [Abstract] [Full Text] [Related]

  • 13. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M, Nishioka E, Kanoh R, Tachibana M, Fukuishi N.
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.
    Martins MA, Silva PM, Faria Neto HC, Bozza PT, Dias PM, Lima MC, Cordeiro RS, Vargaftig BB.
    Br J Pharmacol; 1989 Feb; 96(2):363-71. PubMed ID: 2924083
    [Abstract] [Full Text] [Related]

  • 15. Absence of a lyso-PAF relationship with PAF (platelet activating factor) in monosodium urate crystal-induced inflammatory exudates.
    Griswold DE, Hillegass L, Rotilio D, Mong S, Hanna N.
    Eicosanoids; 1989 Feb; 2(3):151-6. PubMed ID: 2629894
    [Abstract] [Full Text] [Related]

  • 16. The effect of platelet-activating factor (PAF), histamine, and ethanol on vascular permeability of the guinea pig conjunctiva.
    Stock EL, Roth SI, Kim ED, Walsh MK, Thamman R.
    Invest Ophthalmol Vis Sci; 1990 May; 31(5):987-92. PubMed ID: 2335460
    [Abstract] [Full Text] [Related]

  • 17. Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
    Doebber TW, Wu MS, Biftu T.
    J Immunol; 1986 Jun 15; 136(12):4659-68. PubMed ID: 3011900
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.
    Casals-Stenzel J, Muacevic G, Weber KH.
    J Pharmacol Exp Ther; 1987 Jun 15; 241(3):974-81. PubMed ID: 3598913
    [Abstract] [Full Text] [Related]

  • 19. Effect of invertebrate serine proteinase inhibitors on carrageenan-induced pleural exudation and bradykinin release.
    Malavazi-Piza KC, Araújo MS, Godinho RO, Tanaka AS.
    Int Immunopharmacol; 2004 Oct 15; 4(10-11):1401-8. PubMed ID: 15313437
    [Abstract] [Full Text] [Related]

  • 20. PAF-releasing factor in human serum and inflammatory exudate.
    Okamoto Y, Yoshida H, Ino M, Nakamura S, Okamoto G, Mizoguchi K, Suzuki Y, Sugatani J, Miwa M.
    J Lipid Mediat; 1993 Nov 15; 8(3):151-6. PubMed ID: 8268461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.